Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH | ISIN: SE0014855029 | Ticker-Symbol: 8IM1
Tradegate
19.04.24
13:41 Uhr
2,495 Euro
+0,035
+1,42 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
2,4252,47020:34

Aktuelle News zur IMPLANTICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.03.Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)404VADUZ, Liechtenstein, March 27, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the submission of the...
► Artikel lesen
26.03.Implantica completes Human Factors Validation Study for RefluxStop as part of the US FDA Premarket Approval Process379VADUZ, Liechtenstein, March 26, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces completion of the Human...
► Artikel lesen
19.03.Implantica wins another RefluxStop public tender in Europe, this time in Spain with Hospital Universitario de Getafe437VADUZ, Liechtenstein, March 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first-in-the-country...
► Artikel lesen
05.03.Implantica announces another major public hospital purchase agreement win in Italy, further strengthening RefluxStop's broader acceptance in public healthcare systems in Europe249VADUZ, Liechtenstein, March 5, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another public hospital...
► Artikel lesen
16.02.Implantica publishes Year-end Report, January - December 2023 (Q4)331VADUZ, Liechtenstein, Feb. 16, 2024 /PRNewswire/ -- RefluxStop - Gaining speed, breaking boundaries and going global Significant events in the fourth quarter of 2023 Selected U.S....
► Artikel lesen
15.02.Implantica's RefluxStop now available in Munich730VADUZ, Liechtenstein, Feb. 15, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStop...
► Artikel lesen
13.02.Implantica announces first RefluxStop public tender win, paving the way for permanent reimbursement in Italy954VADUZ, Liechtenstein, Feb. 13, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Hospital Santa...
► Artikel lesen
06.02.Implantica continues to expand in Germany with another reflux Center of Excellence in Berlin458VADUZ, Liechtenstein, Feb. 6, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStopTM...
► Artikel lesen
05.02.Implantica presents the fourth quarter 2023 on February 16 at 15:00 CET223VADUZ, Liechtenstein, Dec. 5, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the fourth quarter 2023 at 15:00 CET on February 16. The interim report for...
► Artikel lesen
01.02.Implantica's RefluxStop featured in seven presentations accepted at the largest US GI conference, SAGES311VADUZ, Liechtenstein, Feb. 1, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, reports that seven new scientific...
► Artikel lesen
30.01.Implantica's RefluxStop procedure now available in Norway272VADUZ, Liechtenstein, Jan. 30, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop...
► Artikel lesen
18.12.23Implantica adds another RefluxStop center in Spain311VADUZ, Liechtenstein, Dec. 18, 2023 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospital...
► Artikel lesen
05.12.23Implantica announces live surgery with RefluxStop attended by nearly 2'000 surgeons and streamed by up to 100'000 online475VADUZ, Liechtenstein, Dec. 5, 2023 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that the RefluxStop procedure...
► Artikel lesen
22.11.23Implantica publishes Interim Report January - September 2023 (Q3)406VADUZ, Liechtenstein, Nov. 22, 2023 /PRNewswire/ -- RefluxStop - Beginning of a New Era of Acid Reflux Treatment Significant events in the third quarter of 2023 A big milestone...
► Artikel lesen
21.11.23Implantica's RefluxStopTM, a promising new procedure for chronic acid reflux, offered for the first time in the NHS in UK388VADUZ, Liechtenstein, Nov. 21, 2023 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that the first RefluxStop...
► Artikel lesen
21.11.23Implantica's RefluxStop, a promising new procedure for chronic acid reflux, offered for the first time in the NHS in UK3
17.11.23Implantica presents the third quarter 2023 on November 22 at 15:00 CET334VADUZ, Liechtenstein, Nov. 17, 2023 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the third quarter 2023 at 15:00 CET on November 22. The interim report for...
► Artikel lesen
16.11.23Implantica's RefluxStop health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world's leading European Health-Economics Conference337VADUZ, Liechtenstein, Nov. 16, 2023 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, presented an abstract on cost-effectiveness...
► Artikel lesen
15.11.23Implantica's RefluxStop makes an impact at the leading Annual European Foregut Society Meeting455VADUZ, Liechtenstein, Nov. 15, 2023 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces participation in the...
► Artikel lesen
14.11.23Implantica takes a big step forward at its 2nd Annual RefluxStop Users Meeting316VADUZ, Liechtenstein, Nov. 14, 2023 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces a very successful 2nd...
► Artikel lesen
Seite:  Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3